Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0000950170-25-010117

Chief Scientific Officer sold 2,166 shares at $7.87 ($17,051)

From the SEC's structured data for this filing

Trades in this filing

Burrows Francis · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-28 Sale : show line 1 in the form −846 $7.87 $6,660 22,025 D
2025-01-28 Sale : show line 2 in the form −1,320 $7.87 $10,391 20,705 D
Open-market sales · 2,166 sh · avg $7.87 · $17,051
Loading xslF345X05/ownership.xml…